Aimee Altermatt

Ms. Aimee Altermatt


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
KHKatherine Heath
Katherine Heath
AAAimee Altermatt
Aimee Altermatt
FSFreya Saich
Freya Saich
APAlisa Pedrana
Alisa Pedrana
SFStephanie Fletcher-Lartey
Stephanie Fletcher-Lartey
MHMargaret Hellard
Margaret Hellard
Background: High vaccine uptake requires strong public support, acceptance, and willingness. Methods: A longitudinal cohort study gathered survey data every four weeks between 1 October 2020 and 9 November 2021 in Victoria, Australia. Data were analysed for 686 participants aged 18 years and older. Results: Vaccine intention in our cohort increased from 60% in October 2020 to 99% in November 2021. Vaccine intention increased in all demographics, but longitudinal trends in vaccine intention differed by age, employment as a healthcare worker, presence of children in the household, and highest qualification attained. Acceptance of vaccine mandates increased from 50% in October 2020 to 71% in November 2021. Acceptance of vaccine mandates increased in all age groups except 18–25 years; acceptance also varied by gender and highest qualification attained. The main reasons for not intending to be vaccinated included safety concerns, including blood clots, and vaccine efficacy. Conclusion: COVID-19 vaccination campaigns should be informed by understanding of the sociodemographic drivers of vaccine acceptance to enable socially and culturally relevant guidance and ensure equitable vaccine coverage. Vaccination policies should be applied judiciously to avoid polarisation.

30 September 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
AVAnita Voloshin
Anita Voloshin
AAAimee Altermatt
Aimee Altermatt
AWAnna Wilkinson
Anna Wilkinson
KGKatherine Gibney
Katherine Gibney
SHSophie Hill
Sophie Hill
KHKatherine Heath
Katherine Heath
Background/Objectives: Understanding the psychological determinants of vaccine uptake is critical for effective public health strategies, particularly during prolonged pandemics. The Health Belief Model is widely used to examine vaccine behavior, yet its applicability in longitudinal and policy-intensive contexts remains underexplored. This study assessed how two core Health Belief Model constructs—perceived severity of and susceptibility to COVID-19—related to vaccine intentions and uptake over time, and how these perceptions varied by demographic characteristics. Methods: Data came from Optimise, a longitudinal cohort study of adults in Victoria, Australia, conducted between September 2020 and August 2022. Perceived severity of and susceptibility to COVID-19 were measured monthly, alongside COVID-19 vaccine intentions and uptake. Generalized Estimating Equations evaluated associations between these two Health Belief Model constructs and vaccine outcomes over time. Separate models identified demographic predictors of perceived severity and susceptibility. Results: Perceived severity of COVID-19 was positively associated with intention to receive further COVID-19 vaccine doses (OR = 2.53, 95% CI: 1.26–5.07) and the total vaccine doses received (OR = 2.74, 95% CI: 1.58–4.76), with these associations changing over time as vaccine mandates were lifted and the pandemic context evolved. Perceived susceptibility to COVID-19 showed no significant associations with vaccine outcomes. Older age, presence of a chronic health condition, and lower employment status was associated with higher perceived severity. In contrast, perceived susceptibility was higher among high-income earners but lower among older adults and the unemployed. Conclusions: The predictive value of two Health Belief Model constructs was context- and time-dependent. Perceived severity consistently predicted vaccine uptake once mandates were lifted, while susceptibility did not. Our findings highlight the importance of context-sensitive behavioral frameworks when designing vaccine promotion strategies during extended public health crises.

1 July 2025 in BMJ Public Health
Verified
Journal Article
Open access
PDF file
AAAimee Altermatt
Aimee Altermatt
AWAnna Wilkinson
Anna Wilkinson
KHKatherine Heath
Katherine Heath
DJDefeng Jin
Defeng Jin
TNThi Nguyen
Thi Nguyen
MHMargaret Hellard
Margaret Hellard
Background: It is critical to disseminate all evidence on long COVID’s impact on people’s lives to inform policy and practice. We aimed to assess five measures of well-being, before and after SARS-CoV-2 infection between people with long COVID (defined as symptoms lasting more than 1 month) and people with short COVID (defined as symptoms resolving within 1 month). Methods: Participants from the Optimise Study, a longitudinal cohort study in Victoria, Australia (September 2020–August 2022), had self-reported history of SARS-CoV-2 infection and self-reported long COVID status. Serial cross-sectional analysis compared participants with long and short COVID on Personal Well-being Index, number of COVID-19-like symptoms experienced, number of days exercised and frequency of experiencing positive and negative emotions. Results: 217 participants were included, aged 20–86 years (median age 43, IQR: 31–57), 75% women. Compared with those with short COVID, participants with long COVID had lower well-being before (mean difference (MD)=−8.3, 95% CI (-14.7, –2.0), p-adjusted=0.07), during (MD=−10.3, 95% CI (–16.5, –4.0), p-adjusted=0.03) and after (MD=−9.91, 95% CI (–16.71, –3.11), p-adjusted=0.05) infection and experienced more COVID-19-like symptoms during infection (MD=1.72 (0.72, 2.72), p-adjusted=0.03). In December 2022, 71% (40/56) reported difficulty performing tasks in the past 4 weeks. Conclusion: On average, we observed lower well-being among participants with long COVID, including before SARS-CoV-2 infection, suggesting an underlying difference in well-being between groups. Long COVID continued to impact physical functioning, but ongoing changes were not detected by personal well-being scales.

25 January 2023 in Australian and New Zealand Journal of Public Health
Verified
Journal Article
Open access
AAAimee Altermatt
Aimee Altermatt
KHKatherine Heath
Katherine Heath
FSFreya Saich
Freya Saich
AWAnna Lee Wilkinson
Anna Lee Wilkinson
NSNick Scott
Nick Scott
MHMargaret Hellard
Margaret Hellard
To estimate the proportion of Victorians infected with COVID-19 in January 2022. Between 11-19 February 2022 we conducted a nested cross-sectional survey on experiences of COVID-19 testing, symptoms, test outcome and barriers to testing during January 2022 in Victoria, Australia. Respondents were participants of the Optimise Study, a prospective cohort of adults considered at increased risk of COVID-19 or the unintended consequences of COVID-19-related interventions. Of the 577 participants, 78 (14%) reported testing positive to COVID-19, 240 (42%) did not test in January 2022 and 91 of those who did not test (38%) reported COVID-19-like symptoms. Using two different definitions of symptoms, we calculated symptomatic (27% and 39%) and asymptomatic (4% and 11%) test positivity. We extrapolated these positivity rates to participants who did not test and estimated 19-22% of respondents may have had COVID-19 infection in January 2022. The proportion of Victorians infected with COVID-19 in January 2022 was likely considerably higher than officially reported numbers. Our estimate is approximately double the COVID-19 case numbers obtained from official case reporting. This highlights a major limitation of diagnosis data that must be considered when preparing for future waves of infection.

2 June 2023 in Australian and New Zealand Journal of Public Health
Verified
Journal Article
Open access
WTWai Chung Tse
Wai Chung Tse
AAAimee Altermatt
Aimee Altermatt
FSFreya Saich
Freya Saich
AWAnna L. Wilkinson
Anna L. Wilkinson
KHKatherine Heath
Katherine Heath
MHMargaret Hellard
Margaret Hellard
We describe COVID-19 risk reduction strategies adopted by Victorian adults during December 2021-January 2022, a period of high COVID-19 infection and limited government mandated public health measures. In February 2022, participants of a Victorian-based cohort study (Optimise) completed a cross-sectional survey on risk reduction behaviours during December 2021-January 2022. Regression modelling estimated the association between risk reduction and demographics. A total of 556 participants were included (median age 47 years; 75% women; 82% in metropolitan Melbourne). Two-thirds (61%) adopted at least one risk reduction behaviour, with uptake highest among younger participants (18-34 years; adjusted relative risk (aRR): 1.20, 95% confidence interval [CI]: 1.01, 1.41) and those with a chronic health condition (aRR: 1.17, 95% CI: 1.02, 1.35). Participants adopted their own COVID-19 risk reduction strategies in a setting of limited government restrictions, with young people more likely to adopt a risk reduction strategy that did not limit social mobility. A public health response to COVID-19 that focusses on promoting personal risk reduction behaviours, as opposed to mandated restrictions, could be enhanced by disseminating information on and increasing availability of effective risk reduction strategies tailored to segments of the population.

9 December 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TKTianhui Ke
Tianhui Ke
MLMichael Livingston
Michael Livingston
YZYanqin Zhang
Yanqin Zhang
DPDamian Pavlyshyn
Damian Pavlyshyn
AAAimee Altermatt
Aimee Altermatt
AWAnna Wilkinson
Anna Wilkinson
Objectives: Whilst public health measures were effective in reducing COVID-19 transmission, unintended negative consequences may have occurred. This study aims to assess changes alcohol consumption and the heavy episodic drinking (HED) during the pandemic. Methods: Data were from the Optimise Study, a longitudinal cohort of Australian adults September 2020–August 2022 that over-sampled priority populations at higher risk of contracting COVID-19, developing severe COVID-19 or experiencing adverse consequences of lockdowns. Frequency of alcohol consumption (mean number of days per week) and past-week HED were self-reported. Generalised linear models estimated the association between time and (1) the frequency of alcohol consumption and (2) heavy episodic drinking. Results: Data from 688 participants (mean age: 44.7 years, SD:17.0; 72.7% female) and 10,957 surveys were included. Mean days of alcohol consumption per week decreased from 1.92 (SD: 1.92) in 2020 to 1.54 (SD:1.94) in 2022. The proportion of participants reporting HED decreased from 25.4% in 2020 to 13.1% in 2022. During two lockdown periods, known as “lockdown five”, (OR:0.65, 95%CI [0.47,0.90]) and “lockdown six” (OR:0.76, 95%CI [0.67,0.87]), participants were less likely to report HED. Conclusions: Participants alcohol drinking frequency and HED decreased during the pandemic. This study provides a strong description of alcohol consumption during the pandemic and suggests that lockdowns did not have the unintended consequences of increased alcohol consumption.